Company / Revenue per Share
AbbVie Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$34.50
FY2025
5-year range
$30.57 / $37.87
FY2021-FY2025
Trend
+8.9%
vs FY2024
Sector context
#11 of 152
Health Care
What the data says
Among 152 Health Care companies, AbbVie is in the top 7% for revenue per share. Improved from $30.57 to $34.50 over the past 2 years.
Based on SEC 10-K filings.
34.50 in FY2025 with a 5-year CAGR of +3.1%. Top quartile in the Health Care sector.
Improved from $30.57 to $34.50 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -0.2%
- 5-Year CAGR
- +3.1%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 152This company $34.50 Sector average $10.34
▼
+233.7% above sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 8.9% year-over-year.
- Ranks #11 out of 152 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2021.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $34.50 | +8.9% |
| FY2024 | $31.68 | +3.7% |
| FY2023 | $30.57 | -11.9% |
| FY2022 | $34.70 | -8.4% |
| FY2021 | $37.87 | +27.8% |
| FY2020 | $29.63 | +42.8% |
| FY2019 | $20.75 | +3.3% |
| FY2018 | $20.08 | +16.5% |
| FY2017 | $17.24 | +8.2% |
| FY2016 | $15.92 | +11.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026